ALERT: A Phase II Study of Alternating Eribulin and Hormonal Therapy in Pre-treated ER+ve Breast Cancer.
Status:
Terminated
Trial end date:
2018-07-24
Target enrollment:
Participant gender:
Summary
A single centre, single arm phase II study of alternating eribulin and hormonal therapy in 12
patients with locally advanced or metastatic breast cancer who have received at least one
hormonal therapy and at least one chemotherapy in the metastatic setting.